Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-Dissociative Ketamine for Acute Migraine in the ED
NCT02697071Completed
- Sponsor
- Carilion Clinic
- Start
- Feb 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in migraine comparing Placebo Control with Ketamine (2 arms). Primary endpoint: Achievement of Pain Response After Ketamine Dose at 30 minutes. Started Feb 2016; status: completed.
02
Drugs
ketamine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02697071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697071.